
|Articles|October 10, 2018
FDA Renews and Expands its Use of Certara Software
Advertisement
Certara, a provider of drug development, regulatory science, market access, and real-world evidence solutions, announced that the US Food and Drug Administration has renewed its number of Certara software licenses such as Certara Phoenix, Simcyp, and Synchrogenix GlobalSubmit, for reviewing new drug and biologics applications. Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement